PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (PMCB)

CUSIP: 71715X203

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
+115,563
Put/Call ratio
1282%
SEC-reported price per share
$2.25
Number of holders
24
Value change
+$254,010
Number of buys
15
Open additional details 1 more signal available
Number of sells
7
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
10,666,413

Security key

71715X203

Report period

Q2 2022

Institutions

24

Top holders

10

Ownership snapshot

Top reported holders of PMCB - PharmaCyte Biotech, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership Top 5
SABBY MANAGEMENT, LLC 12%
Shay Capital LLC 8.9%
VANGUARD GROUP INC 5.8%
EQUITEC PROPRIETARY MARKETS, LLC 2.9%
GEODE CAPITAL MANAGEMENT, LLC 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SABBY MANAGEMENT, LLC
13F
Company
13F
12%
$2,934,000
1,275,468 shares
31 Mar 2022
Shay Capital LLC
13F
Company
13F
8.9%
$2,173,000
944,666 shares
31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
5.8%
$1,414,000
614,625 shares
31 Mar 2022
EQUITEC PROPRIETARY MARKETS, LLC
13F
Company
13F
2.9%
$711,000
309,294 shares
31 Mar 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
1.6%
$394,000
171,523 shares
31 Mar 2022
Ayrton Capital LLC
13F
Company
13F
1.4%
$352,000
153,130 shares
31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
24
Shares
3,920,480
Rows available
24
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
19
Q2 2022 holders
24
Holder diff
5
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .